In silico models for nanotoxicity evaluation and prediction at the blood-brain barrier level: A mini-review
暂无分享,去创建一个
Sergey Shityakov | Norbert Roewer | Carola Förster | N. Roewer | C. Förster | S. Shityakov | J. Broscheit | Jens-Albert Broscheit
[1] Shui-Tein Chen,et al. Targeting the delivery of glycan-based paclitaxel prodrugs to cancer cells via glucose transporters. , 2008, Journal of medicinal chemistry.
[2] I. Ivanov,et al. Comparative Study of Predictive Computational Models for Nanoparticle‐Induced Cytotoxicity , 2010, Risk analysis : an official publication of the Society for Risk Analysis.
[3] Sergey Shityakov,et al. Multidrug resistance protein P-gp interaction with nanoparticles (fullerenes and carbon nanotube) to assess their drug delivery potential: a theoretical molecular docking study , 2013, Int. J. Comput. Biol. Drug Des..
[4] N. Roewer,et al. Claudin-5 as a Novel Estrogen Target in Vascular Endothelium , 2010, Arteriosclerosis, thrombosis, and vascular biology.
[5] B. Ruozi,et al. Nanomedicine: the future for advancing medicine and neuroscience. , 2012, Nanomedicine.
[6] C. Förster,et al. α-Cyclodextrin dimer complexes of dopamine and levodopa derivatives to assess drug delivery to the central nervous system: ADME and molecular docking studies , 2012, International journal of nanomedicine.
[7] P. Aebischer,et al. Repair of the blood-brain barrier following implantation of polymer capsules , 1991, Brain Research.
[8] Cesar A. López,et al. Molecular Mechanism of Cyclodextrin Mediated Cholesterol Extraction , 2011, PLoS Comput. Biol..
[9] M. Yoneya,et al. Simulation of metal-organic framework self-assembly. , 2015, Physical chemistry chemical physics : PCCP.
[10] Ting Zhang,et al. Metal Oxide Nanomaterial QNAR Models: Available Structural Descriptors and Understanding of Toxicity Mechanisms , 2015, Nanomaterials.
[11] Gerd Ulrich Nienhaus,et al. New views on cellular uptake and trafficking of manufactured nanoparticles , 2013, Journal of The Royal Society Interface.
[12] Jianpeng Ma,et al. Molecular dynamics analysis of a buckyball–antibody complex , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[13] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .
[14] Rein V. Ulijn,et al. Virtual Screening for Dipeptide Aggregation: Toward Predictive Tools for Peptide Self-Assembly , 2011, The journal of physical chemistry letters.
[15] I. Toth,et al. Cellular transport pathways of polymer coated gold nanoparticles. , 2012, Nanomedicine : nanotechnology, biology, and medicine.
[16] Omid Akhavan,et al. Toxicity of graphene and graphene oxide nanowalls against bacteria. , 2010, ACS nano.
[17] Yu-qiang Ma,et al. Design strategy of surface decoration for efficient delivery of nanoparticles by computer simulation , 2016, Scientific Reports.
[18] T. Xia,et al. Toxic Potential of Materials at the Nanolevel , 2006, Science.
[19] U. Heinzmann,et al. Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats. , 2001, Environmental health perspectives.
[20] Gabriel A. Silva,et al. Neuroscience nanotechnology: progress, opportunities and challenges , 2006, Nature Reviews Neuroscience.
[21] R. Breslow,et al. Synthesis and binding properties of cyclodextrin trimers , 2001 .
[22] Haiping Fang,et al. Destructive extraction of phospholipids from Escherichia coli membranes by graphene nanosheets. , 2013, Nature nanotechnology.
[23] Fang Huang,et al. Molecular modeling of interaction between lipid monolayer and graphene nanosheets: implications for pulmonary nanotoxicity and pulmonary drug delivery , 2015 .
[24] Sergey Shityakov,et al. In silico predictive model to determine vector-mediated transport properties for the blood–brain barrier choline transporter , 2014, Advances and applications in bioinformatics and chemistry : AABC.
[25] Ken-Tye Yong,et al. Theranostic quantum dots for crossing blood–brain barrier in vitro and providing therapy of HIV-associated encephalopathy , 2013, Front. Pharmacol..
[26] M. Másson,et al. Influence of aqueous diffusion layer on passive drug diffusion from aqueous cyclodextrin solutions through biological membranes. , 2006, Die Pharmazie.
[27] Jingyuan Li,et al. A Peptide-Coated Gold Nanocluster Exhibits Unique Behavior in Protein Activity Inhibition. , 2015, Journal of the American Chemical Society.
[28] Jiaqi Lin,et al. Penetration of lipid membranes by gold nanoparticles: insights into cellular uptake, cytotoxicity, and their relationship. , 2010, ACS nano.
[29] D. Mager,et al. Effect of Repetitive Administration of Doxorubicin-Containing Liposomes on Plasma Pharmacokinetics and Drug Biodistribution in a Rat Brain Tumor Model , 2005, Clinical Cancer Research.
[30] Fred Wudl,et al. Inhibition of the HIV-1 protease by fullerene derivatives: model building studies and experimental verification , 1993 .
[31] Stefan Hiermaier,et al. A Review of Computational Methods in Materials Science: Examples from Shock-Wave and Polymer Physics , 2009, International journal of molecular sciences.
[32] Ki-Tae Ha,et al. Effect of ZnO nanoparticles aggregation on the toxicity in RAW 264.7 murine macrophage. , 2014, Journal of hazardous materials.
[33] R. Vandenbroucke,et al. Into rather unexplored terrain—transcellular transport across the blood–brain barrier , 2016, Glia.
[34] J. Lellouche,et al. The effect of nanoparticle size on the probability to cross the blood-brain barrier: an in-vitro endothelial cell model , 2015, Journal of Nanobiotechnology.
[35] R. Radhakrishnan,et al. Coarse-Grained Models for Protein-Cell Membrane Interactions , 2013, Polymers.
[36] P. Angelikopoulos,et al. Homogeneous Hydrophobic-Hydrophilic Surface Patterns Enhance Permeation of Nanoparticles through Lipid Membranes. , 2013, The journal of physical chemistry letters.
[37] Ali Majdi,et al. Nanotoxicology and nanoparticle safety in biomedical designs , 2011, International journal of nanomedicine.
[38] Olivier Jolliet,et al. Toward a general physiologically-based pharmacokinetic model for intravenously injected nanoparticles , 2016, International journal of nanomedicine.
[39] Olivier Jolliet,et al. Physiologically based pharmacokinetic modeling of polyethylene glycol-coated polyacrylamide nanoparticles in rats , 2014, Nanotoxicology.
[40] C. Förster,et al. Occludin as direct target for glucocorticoid‐induced improvement of blood–brain barrier properties in a murine in vitro system , 2005, The Journal of physiology.
[41] Tamás Sohajda,et al. Ionization States, Cellular Toxicity and Molecular Modeling Studies of Midazolam Complexed with Trimethyl-β-Cyclodextrin , 2014, Molecules.
[42] A. Panagiotopoulos,et al. Dynamics in coarse-grained models for oligomer-grafted silica nanoparticles. , 2012, The Journal of chemical physics.
[43] T. Davis,et al. The Blood-Brain Barrier/Neurovascular Unit in Health and Disease , 2005, Pharmacological Reviews.
[44] V. Ryzhov,et al. Zero-valent Fe confined mesoporous silica nanocarriers (Fe(0) @ MCM-41) for targeting experimental orthotopic glioma in rats , 2016, Scientific Reports.
[45] Bingqian Xu,et al. Cholesterol Extraction from Cell Membrane by Graphene Nanosheets: A Computational Study. , 2016, The journal of physical chemistry. B.
[46] Thomas R Weikl,et al. Modeling nanoparticle wrapping or translocation in bilayer membranes. , 2015, Nanoscale.
[47] C. K. Nandi,et al. Morphological effect of gold nanoparticles on the adsorption of bovine serum albumin. , 2014, Physical chemistry chemical physics : PCCP.
[48] A. Violi,et al. A Coarse-Grained Molecular Dynamics Study of Carbon Nanoparticle Aggregation. , 2006, Journal of chemical theory and computation.
[49] I. Yu,et al. Toxicity of various silver nanoparticles compared to silver ions in Daphnia magna , 2012, Journal of Nanobiotechnology.
[50] Mauro Ferrari,et al. In silico vascular modeling for personalized nanoparticle delivery. , 2013, Nanomedicine.
[51] Ebrahim Ghafar-Zadeh,et al. Modeling and simulation of crossing magnetic nanoparticles through Blood Brain Barrier (BBB) , 2014, 2014 36th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.
[52] Lie-Chwen Lin,et al. Curcumin and its nano-formulation: the kinetics of tissue distribution and blood-brain barrier penetration. , 2011, International journal of pharmaceutics.
[53] Catherine J. Murphy,et al. Toxicity and cellular uptake of gold nanoparticles: what we have learned so far? , 2010, Journal of nanoparticle research : an interdisciplinary forum for nanoscale science and technology.
[54] C. Förster,et al. Glucocorticoids and endothelial cell barrier function , 2013, Cell and Tissue Research.
[55] Kazuo T. Suzuki,et al. Mechanism of cadmium-induced cytotoxicity in rat hepatocytes: cadmium-induced active oxygen-related permeability changes of the plasma membrane , 1996 .
[56] Alessandra Nurisso,et al. MLP Tools: a PyMOL plugin for using the molecular lipophilicity potential in computer-aided drug design , 2014, Journal of Computer-Aided Molecular Design.
[57] Jing Kong,et al. Antibacterial activity of graphite, graphite oxide, graphene oxide, and reduced graphene oxide: membrane and oxidative stress. , 2011, ACS nano.
[58] S. Rocchiccioli,et al. Rational Design of a Transferrin-Binding Peptide Sequence Tailored to Targeted Nanoparticle Internalization. , 2017, Bioconjugate chemistry.
[59] Tomasz Puzyn,et al. Development of a novel in silico model of zeta potential for metal oxide nanoparticles: a nano-QSPR approach , 2016, Nanotechnology.
[60] Arthur W. Toga,et al. Blood-Brain Barrier Breakdown in the Aging Human Hippocampus , 2015, Neuron.
[61] J. Kreuter,et al. Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles) , 1995, Brain Research.
[62] Tetsuya Osaka,et al. Effect of surface charge of magnetite nanoparticles on their internalization into breast cancer and umbilical vein endothelial cells. , 2009, Colloids and surfaces. B, Biointerfaces.
[63] A. A. Gurtovenko,et al. Microsecond Atomic-Scale Molecular Dynamics Simulations of Polyimides , 2013 .
[64] U. Welsch,et al. The contribution of the capillary endothelium to blood clearance and tissue deposition of anionic quantum dots in vivo. , 2010, Biomaterials.
[65] Rodney F. Minchin,et al. Plasma protein binding of positively and negatively charged polymer-coated gold nanoparticles elicits different biological responses , 2012, Nanotoxicology.
[66] Ruhong Zhou,et al. Molecular mechanism of pancreatic tumor metastasis inhibition by Gd@C82(OH)22 and its implication for de novo design of nanomedicine , 2012, Proceedings of the National Academy of Sciences.
[67] G. Pastorin,et al. Blood–brain barrier transport studies, aggregation, and molecular dynamics simulation of multiwalled carbon nanotube functionalized with fluorescein isothiocyanate , 2015, International journal of nanomedicine.
[68] Sang-Jae Kim,et al. Antibacterial Efficiency of Graphene Nanosheets against Pathogenic Bacteria via Lipid Peroxidation , 2012 .
[69] Panagiotis Angelikopoulos,et al. Membrane Partitioning of Anionic, Ligand-Coated Nanoparticles Is Accompanied by Ligand Snorkeling, Local Disordering, and Cholesterol Depletion , 2014, PLoS Comput. Biol..
[70] John Schlager,et al. Influence of nanoparticles on blood-brain barrier permeability and brain edema formation in rats. , 2010, Acta neurochirurgica. Supplement.
[71] Xue Xu,et al. Multidrug resistance protein P-glycoprotein does not recognize nanoparticle C60: experiment and modeling , 2012 .
[72] Jinwoo Cheon,et al. Exchange-coupled magnetic nanoparticles for efficient heat induction. , 2011, Nature nanotechnology.
[73] Gert Fricker,et al. Nanotoxicity of poly(n-butylcyano-acrylate) nanoparticles at the blood-brain barrier, in human whole blood and in vivo. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[74] Arun K Mandagere,et al. Graphical model for estimating oral bioavailability of drugs in humans and other species from their Caco-2 permeability and in vitro liver enzyme metabolic stability rates. , 2002, Journal of medicinal chemistry.
[75] Wim E Hennink,et al. Cyclodextrin-based polymeric materials: synthesis, properties, and pharmaceutical/biomedical applications. , 2009, Biomacromolecules.
[76] J. Crison,et al. A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability , 1995, Pharmaceutical Research.
[77] R. E. Salmas,et al. Evaluation of the potential toxicity of unmodified and modified cyclodextrins on murine blood-brain barrier endothelial cells. , 2016, The Journal of toxicological sciences.
[78] A. Alasty,et al. Computing the blood brain barrier (BBB) diffusion coefficient: A molecular dynamics approach , 2016 .
[79] M. Másson,et al. Cyclodextrins in topical drug formulations: theory and practice. , 2001, International journal of pharmaceutics.
[80] M. Zloh,et al. Computational classification models for predicting the interaction of drugs with P-glycoprotein and breast cancer resistance protein , 2014, SAR and QSAR in environmental research.
[81] Saber M Hussain,et al. Modeling the In Vivo Case with In Vitro Nanotoxicity Data , 2008, International journal of toxicology.
[82] J. Kirkland,et al. Lipid peroxidation, protein thiol oxidation and DNA damage in hydrogen peroxide-induced injury to endothelial cells: role of activation of poly(ADP-ribose)polymerase. , 1991, Biochimica et biophysica acta.